Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
PMID: 25041349
This strategy involves administering smaller-than-standard doses to harness the metabolic and protective benefits of GLP-1 activation while minimizing side effects, cost, and rapid weight loss
Retatrutide (development code LY3437943) is a once-weekly subcutaneous peptide that activates three receptors: the glucagon receptor (GcGR), the GIP receptor, and the GLP-1 receptor
This triple-agonist approach is what sets it apart from earlier GLP-1 medications
Reconstitution follows standard peptide protocols
US$ 29.90
US$ 24.04
US$ 21.61
US$ 24.90
